Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from XBiotech ( (XBIT) ) is now available.
On March 27, 2025, W. Thorpe McKenzie retired from the Board of Directors of XBiotech Inc., a company in the biotechnology sector, after serving since 2009. His departure was amicable and not due to any disputes. The company plans to maintain a one-member Audit Committee temporarily and intends to fill the vacancies in compliance with NASDAQ rules.
More about XBiotech
XBiotech Inc. operates in the biotechnology industry, focusing on developing therapies for various diseases.
YTD Price Performance: -22.30%
Average Trading Volume: 51,270
Technical Sentiment Signal: Buy
Current Market Cap: $94.51M
See more data about XBIT stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money